Association of Procalcitonin Level with the Severity of Pneumonia in Children under 5 Years of Age: A Prospective Cohort Study

Association of Procalcitonin Level with the Severity of Pneumonia in Children under 5 Years of Age: A Prospective Cohort Study

Introduction: Community Acquired Pneumonia (CAP) is a significant global health problem, with notable variations in incidence, causative pathogens, and outcomes across different regions and populations. Procalcitonin (PCT) has been established as a marker of bacterial infection to differentiate sept...

Full description

Saved in:

Bibliographic Details
Main Authors:	P Ananya, SS Kalyanshettar, Trimal P Kulkarni, Mallanagouda M Patil
Format:	Article
Language:	English
Published:	JCDR Research and Publications Private Limited 2025-08-01
Series:	Journal of Clinical and Diagnostic Research
Subjects:	acute illness observation scale biomarkers of severity calcitonin precursor community acquired infection
Online Access:	https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2025&volume=19&issue=8&page=SC09&issn=0973-709x&id=21408
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Problems of assessing the severity of the state of elderly patients with community-acquired pneumonia caused by Klebsiella pneumoniae
by: V. I. Sakharov, et al.
Published: (2020-12-01)

Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia
by: Lin Y, et al.
Published: (2024-12-01)

The Burden of Hospitalization and Rehospitalization Among Patients Hospitalized with Severe Community-Acquired Bacterial Pneumonia in the United States, 2018–2022
by: Marya D. Zilberberg, et al.
Published: (2025-06-01)

Respiratory dysbiosis as prognostic biomarker of disease severity for adults with community-acquired pneumonia requiring mechanical ventilation
by: Loreto Vidaur, et al.
Published: (2025-05-01)

Accuracy of Procalcitonin in Detecting Severe Bacterial Infections Among Critically III Children
by: Kantimas Sitthikool, et al.
Published: (2020-01-01)

Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Nonlinear main components of the cytokine profile in children with community-acquired pneumonia
by: N. V. Iziurova, et al.
Published: (2024-01-01)

Assessment of the prognosis of the outcome of severe community-acquired pneumonia caused by <i>Klebsiella pneumoniae</i>
by: V. I. Sakharov, et al.
Published: (2023-12-01)

Associations of serum MANF with severity and prognosis in community-acquired pneumonia patients
by: Wen-Nan Wang, et al.
Published: (2025-04-01)

Procalcitonin and BISAP score versus c-reactive protein and APACHE II score in early assessment of severity and outcome of acute pancreatitis
by: Bezmarević Mihailo, et al.
Published: (2012-01-01)

Longitudinal relationships between serum ferritin and prognosis among severe community-acquired pneumonia patients
by: Jing Xu, et al.
Published: (2025-05-01)

Risk factors and prediction model construction for poor outcome in asthma combined with severe community-acquired pneumonia in children
by: WANG Fanrong, et al.
Published: (2024-05-01)

Assessment of disease severity in hospitalized community-acquired pneumonia by the use of validated scoring systems
by: Sandleen Iftikhar, et al.
Published: (2025-03-01)

Predictive value of different severity scoring systems in patients with community acquired pneumonia
by: Amira H. Allam, et al.
Published: (2025-01-01)

Glucocorticoids can reduce mortality in patients with severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials
by: Xue Gu, et al.
Published: (2025-03-01)

Clinical characteristics of severe community-acquired pneumonia in children with virus mono-detection versus co-detection with bacteria
by: Qian Chen, et al.
Published: (2025-03-01)

The Role of Calcitonin and Vitamin D in patients with Chronic Renal Failure and Arthritis
by: Nazar Ahemd Naji, et al.
Published: (2023-02-01)

Efficacy and safety of glucocorticoids therapy of severe community-acquired pneumonia in older adults: a systematic review and meta-analysis
by: Mure Ali, et al.
Published: (2025-04-01)

Case report: The value of early application of mNGS technology in the diagnosis and treatment of severe Legionnaires’ disease: reports of two cases with different outcomes
by: Jianqing Fang, et al.
Published: (2025-02-01)

Differences in pulmonary microbiota of severe community-acquired pneumonia with different pathogenic microorganisms in children
by: Yingying Luo, et al.
Published: (2025-06-01)

Antibacterial Therapy of Severe Community-Acquired Pneumonia in Adults - Is There a Need for New Drugs?
by: S. A. Rachina, et al.
Published: (2020-05-01)

Mental capacity, insight, and severity of illness in psychiatric in-patients: A prospective study
by: N Aman, et al.
Published: (2025-04-01)

Predictors and etiology of healthcare-associated infections in patients with severe community-acquired pneumonia
by: I. A. Ruslyakova, et al.
Published: (2025-02-01)

Strategy for Procalcitonin-Controlled Antimicrobial Therapy in the COVID-19 Pandemic
by: A. A. Zaytsev, et al.
Published: (2022-11-01)

Efficacy of Scoring Systems for Routing and Predicting Length of ICU Stay in Severe Community-Acquired Pneumonia
by: Irina A. Ruslyakova, et al.
Published: (2025-02-01)

Effectiveness of pneumococcal conjugate 13-valent vaccine against severe pneumonia in Panama: a matched case-control study
by: Jacqueline Levy, et al.
Published: (2025-07-01)

Microbial and clinical disparities in pneumonia: insights from metagenomic next-generation sequencing in patients with community-acquired and severe pneumonia
by: Wang Luo, et al.
Published: (2025-06-01)

Plasma level of calcitonin gene-related peptide in the diagnosis of episodic migraine with comorbid conditions
by: O. Ye. Dubenko, et al.
Published: (2022-12-01)

Retrospective analysis of patients with immediate decannulation in severe acquired brain injury (RAPID-SABI)
by: Robbert-Jan van Hooff, et al.
Published: (2025-02-01)

A Comparative Cross-sectional Study to Assess Knowledge Regarding Human Rights of Mentally Ill between Patient with Severe Mental Illness and People Without Mental Illness
by: Rashmi Rawat, et al.
Published: (2025-04-01)

Respiratory pathogens detected in children aged <5 years hospitalized with severe respiratory illness, South Africa, 2017
by: Malefu Moleleki, et al.
Published: (2025-06-01)

Incidence and risk factor of sepsis in patients with severe community-acquired pneumonia: a Chinese, single-center, retrospective study
by: Xinyu Wang, et al.
Published: (2025-05-01)

Serum cytokine levels in children with community-acquired pneumonia caused by different respiratory pathogens
by: Yuanhui Duan, et al.
Published: (2025-05-01)

Neutrophil-to-lymphocyte ratio in predicting prognosis and course of community community-acquired pneumonia in hospitalized patients.
by: T. O. Pertseva, et al.
Published: (2018-04-01)

Composite bioscore is superior to routine biomarkers and established scoring systems in predicting mortality in adult critically ill patients with secondary sepsis
by: Rondović Goran, et al.
Published: (2021-01-01)

Randomized controlled trial: the safety and efficacy of adjunctive corticosteroids through the clinical course of severe hospital-acquired pneumonia
by: Safaa M. M. Wafy, et al.
Published: (2025-01-01)

Prediction of mortality risk in patients with severe community-acquired pneumonia in the intensive care unit using machine learning
by: Jingjing Pan, et al.
Published: (2025-01-01)

Prognostic value of peripheral blood lymphocytes in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2025-06-01)

Cytokine profile in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2022-11-01)